You can read results from the 2018 pilot Spring ETW presented at the 2018 European Harm Reduction Conference here.

What is Spring European Testing Week?

#SpringTestingWeek serves as another opportunity during the year to support ETW's main aim: to increase access to testing and increase awareness of the benefits of earlier testing for hepatitis and HIV.

The aim of #SpringTestingWeek is to promote wide-scale testing and related awareness activities with a focus on integrated activities for infectious diseases including sexually transmitted infections (STIs), in addition to viral hepatitis and HIV as a way to complement the Autumn (November) campaign.

#SpringTestingWeek is not replacingthe Autumn European Testing Week that occurs during the last week of November. The European Testing Week initiative will still carry out Testing Week in November 2019.

When is it?

The Spring European Testing Week is from 17 - 24 May 2019.

Who can participate?

All interested organisations, at the local and national level, can sign up to participate. There is no minimum requirement for partcipation.

It is not a requirement to participate in #SpringTestingWeek, you can participate in whichever ETW (Spring or Autumn) that you prefer.

How can you get involved?

Registration to participate is now open! Sign up on the ETW website here.

There are many activities that you and your organisation can do for the Spring Testing Week.They can include activities such as:

Awareness raising activities for key populations at higher risk

Hepatitis and/or HIV testing outreach activities for key populations

Promotion of combined testing at your site, on social media and much more.

If you need some inspiration for your #SpringTestingWeek activities, check out our success stories page!

Monitoring & Evaluation

Your participation would also mean closely monitoring and evaluating your Spring ETW activities. We will rely on your feedback during the post-Spring ETW evaluation. Check back here at the end of Spring ETW for the link to the online evaluation survey.

Sponsorship statement: The EuroTEST initiative is governed by an independent steering committee. The Coordinating Centre is at CHIP, RegionH, Copenhagen, and the political secretariat at the EATG. The conditions of funding the initiative are approved by the Steering Committee. Industry sponsors are invited to quarterly updates but do not participate in the Steering Committee.

Financial support of the EuroTEST initiative provided by: Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Danish National Research Foundation (grant 126), European Commission under the 3rd and 2nd Health Programmes, European Centre for Disease Prevention and Control (ECDC), Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Schering-Plough, Swedish Research Council, ViiV Healthcare and Tibotec.

This site uses cookies
We use cookies to analyze our traffic and provide a better user experience. You give your consent by clicking on the OK button or choose to continue.